Navigation Links
US, European cholesterol guidelines differ in statin use recommendations
Date:3/29/2014

Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.

The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle interventions, treatment with medications, or both. The CVD prevention guidelines developed by the National Cholesterol Education Program expert panel, the American College of Cardiology/American Heart Association (ACC/AHA) task force, and the European Society of Cardiology (ESC) are the major guidelines influencing clinical practice. "Varying approaches to CVD risk estimation and application of different criteria for therapeutic recommendations would translate into substantial differences in proportions of individuals qualifying for treatment at a population level," the authors write.

Maryam Kavousi, M.D., Ph.D., of Erasmus MC-University Medical Center, Rotterdam, the Netherlands, and colleagues conducted a study to determine population-wide implications of the ACC/AHA, the Adult Treatment Panel III (ATP-III), and the ESC guidelines, using 4,854 Dutch participants from the Rotterdam Study (a population-based study of patients 55 years of age or older). The researchers calculated 10-year risks for "hard" (major) atherosclerotic cardiovascular disease (ASCVD) events (including fatal and nonfatal coronary heart disease [CHD] and stroke) (ACC/AHA); hard CHD events (fatal and nonfatal heart attack, CHD mortality) (ATP-III); and atherosclerotic CVD mortality (ESC). The proportions of individuals for whom statins would be recommended were calculated per guideline.

The average age of the participants was 65.5 years; 54.5 percent were women. The researchers found that application of the ACC/AHA guideline recommended treatment for 96.4 percent of men and 65.8 percent of women; for the ATP-III guideline, the portion was 52 percent of men and 35.5 percent of women; and for the ESC guideline, 66.1 percent of men and 39.1 percent of women were included in the category where treatment was recommended.

With the ACC/AHA approach, average predicted risk vs observed major ASCVD events was 21.5 percent vs 12.7 percent for men and 11.6 percent vs 7.9 percent for women. Similar overestimation occurred with the ATP-III and ESC model.

"Improving risk predictions and setting appropriate population-wide thresholds are necessary to facilitate better clinical decision making," the authors conclude.


'/>"/>

Contact: Maryam Kavousi, M.D., Ph.D.
m.kavousi@erasmusmc.nl
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Better nurse staffing and education reduces patient deaths in European hospitals
2. European Home Healthcare Market (Respiratory Therapy, Rehabilitation Therapy) worth $57.2 Billion by 2017 - New Report by MarketsandMarkets
3. European Anesthesia, Respiratory and Sleep Management Device Market
4. Selexis SA Names Dr. Marco Bocci Director of European Sales and Business Development
5. European Market for Multiparameter Patient Monitoring Solutions
6. 22 million women aged over 50 are affected by osteoporosis in the European Union
7. A*STAR scientist wins European Molecular Biology Organization Young Investigator award
8. European Markets for Dental Prosthetics and CAD/CAM Devices
9. European Market for Remote Patient Monitoring Applications
10. European Food Safety Testing Market (Pathogen, GMO, Toxin, Pesticide) Worth $4,068.8 Million by 2018 - New Report by MarketsandMarkets
11. Ganeden Biotech Announces UK-based Leatherhead Food Research As Its Approved European Testing Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2020)... ... ... Bay-Bay Water today announced that the company has launched a new logo. , ... of the ongoing evolution of our company’s brand,” said Osmay Gonzalez, spokesperson of the company. ... national reach. , “We have refreshed our logo to reflect who we are today and ...
(Date:2/20/2020)... (PRWEB) , ... February 20, 2020 , ... R3 Medical ... Las Vegas Nevada. Providers will learn how to perform injections for all large and ... not easy to learn from online videos. The best opportunity is to perform injections ...
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Richard Amato, Michael ... of Connecticut, celebrate 30 years of serving Monroe, CT with a “Throwback Special” ... they charged in 1989, only thirty dollars. To further serve their patients, they ...
(Date:2/19/2020)... ... 2020 , ... BPM+ Health , a community initiative ... participate in the HIMSS20 Global Health Conference & Exhibition, March 9 ... other stakeholders at HIMSS20 – the largest global health information and technology event ...
(Date:2/16/2020)... ... ... Canadian digital healthcare portal Ask The Doctor has launched a toll-free number ... "It is our duty and it is our responsibility to help people around the ... of Ask The Doctor. , Doctors and nurses around the globe are available around ...
Breaking Medicine News(10 mins):
(Date:2/19/2020)... , ... February 19, 2020 , ... A new study ... of oxygen-deprived clusters throughout the damaged site of a compressed spinal cord. It is ... a viral vector to target the oxygen-deprived sites enhances the injured spinal cord’s recovery. ...
(Date:2/19/2020)... Va. (PRWEB) , ... February 19, 2020 , ... ... of various types of platforms. Molecular diagnostics platforms are increasingly becoming popular as ... treatment decisions. In 2019, the market for molecular cancer diagnostics, including histology and ...
(Date:2/19/2020)... ... 2020 , ... Global Healthcare Exchange, LLC (GHX) ... its annual GHX “Best 50” supply chains in North America. The ... to demonstrate improved operational performance and drive down costs through supply chain automation. ...
Breaking Medicine Technology: